REFERENCES
[1] Kim Seon-min (2017) – “Ginseng and Borderland: Territorial Boundaries and Political Relations Between Qing China and Choson Korea” University of California Press
[2] Shin MS, Song JH, Choi P, Lee JH, Kim SY, Shin KS, Ham J, Kang KS (2018) – “Stimulation of Innate Immune Function by Panax ginseng after Heat Processing.” J Agric Food Chem. 2018 May 9;66(18):4652-4659. doi: 10.1021/acs.jafc.8b00152. Epub 2018 Apr 26.
[3] Liu X, Zhang Z, Liu J, Wang Y, Zhou Q, Wang S, Wang X (2019) – “Ginsenoside Rg3 improves cyclophosphamide-induced immunocompetence in Balb/c mice.” Int Immunopharmacol. 2019 Jul;72:98-111. doi: 10.1016/j.intimp.2019.04.003. Epub 2019 Apr 8.
[4] Lee JS, Hwang HS, Ko EJ, Lee YN, Kwon YM, Kim MC, Kang SM (2014) – “Immunomodulatory activity of red ginseng against influenza A virus infection.” Nutrients. 2014 Jan 27;6(2):517-29. doi: 10.3390/nu6020517.
[5] Nguyen NH, Nguyen CT (2019) – “Pharmacological effects of ginseng on infectious diseases.” Inflammopharmacology. 2019 Oct;27(5):871-883. doi: 10.1007/s10787-019-00630-4. Epub 2019 Aug 12.
[6] Xin C, Kim J, Quan H, Yin M, Jeong S, Choi JI, Jang EA, Lee CH, Kim DH, Bae HB (2019) – “Ginsenoside Rg3 promotes Fc gamma receptor-mediated phagocytosis of bacteria by macrophages via an extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent mechanism.” Int Immunopharmacol. 2019 Dec;77:105945. doi: 10.1016/j.intimp.2019.105945. Epub 2019 Oct 20.
[7] Liu X, Zhang Z, Liu J, Wang Y, Zhou Q, Wang S, Wang X (2019) – “Ginsenoside Rg3 improves cyclophosphamide-induced immunocompetence in Balb/c mice.” Int Immunopharmacol. 2019 Jul;72:98-111. doi: 10.1016/j.intimp.2019.04.003. Epub 2019 Apr 8.
[8] Shin JY, Song JY, Yun YS, Yang HO, Rhee DK, Pyo S (2002) – “Immunostimulating effects of acidic polysaccharides extract of Panax ginseng on macrophage function.” Immunopharmacol Immunotoxicol. 2002 Aug;24(3):469-82.
[9] Seo JY, Choi JW, Lee JY, Park YS, Park YI (2018) – “Enzyme Hydrolysates of Ginseng Marc Polysaccharides Promote the Phagocytic Activity of Macrophages Via Activation of TLR2 and Mer Tyrosine Kinase.” J Microbiol Biotechnol. 2018 Jun 28;28(6):860-873. doi: 10.4014/jmb.1801.01003.
[10] Kim TW, Joh EH, Kim B, Kim DH (2012) – “Ginsenoside Rg5 ameliorates lung inflammation in mice by inhibiting the binding of LPS to toll-like receptor-4 on macrophages.” Int Immunopharmacol. 2012 Jan;12(1):110-6. doi: 10.1016/j.intimp.2011.10.023. Epub 2011 Nov 19.
[11] Ahn S, Siddiqi MH, Aceituno VC, Simu SY, Zhang J, Jimenez Perez ZE, Kim YJ, Yang DC (2016) – “Ginsenoside Rg5:Rk1 attenuates TNF-α/IFN-γ-induced production of thymus- and activation-regulated chemokine (TARC/CCL17) and LPS-induced NO production via downregulation of NF-κB/p38 MAPK/STAT1 signaling in human keratinocytes and macrophages.” In Vitro Cell Dev Biol Anim. 2016 Mar;52(3):287-295. doi: 10.1007/s11626-015-9983-y. Epub 2015 Dec 29.
[12] Yu Q, Zeng KW, Ma XL, Jiang Y, Tu PF, Wang XM (2017) – “Ginsenoside Rk1 suppresses pro-inflammatory responses in lipopolysaccharide-stimulated RAW264.7 cells by inhibiting the Jak2/Stat3 pathway.” Chin J Nat Med. 2017 Oct;15(10):751-757. doi: 10.1016/S1875-5364(17)30106-1.
[13] Shi Y, Wang H, Zheng M, Xu W, Yang Y, Shi F (2020) – “Ginsenoside Rg3 suppresses the NLRP3 inflammasome activation through inhibition of its assembly.” FASEB J. 2020 Jan;34(1):208-221. doi: 10.1096/fj.201901537R. Epub 2019 Nov 20.
[14] Lee JW, Choi YR, Mok HJ, Seong HA, Lee DY, Kim GS, Yoon JH, Kim KP, Kim HD (2017) – “Characterization of the changes in eicosanoid profiles of activated macrophages treated with 20(S)-ginsenoside Rg3.” J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Oct 15;1065-1066:14-19. doi: 10.1016/j.jchromb.2017.09.002. Epub 2017 Sep 5.
[15] Lee YY, Saba E, Irfan M, Kim M, Chan JY, Jeon BS, Choi SK, Rhee MH (2019) – “The anti-inflammatory and anti-nociceptive effects of Korean black ginseng.” Phytomedicine. 2019 Feb 15;54:169-181. doi: 10.1016/j.phymed.2018.09.186. Epub 2018 Sep 18.
[16] Adam GO, Kim GB, Lee SJ, Lee H, Kang HS, Kim SJ (2019) – “Red Ginseng Reduces Inflammatory Response via Suppression MAPK/P38 Signaling and p65 Nuclear Proteins Translocation in Rats and Raw 264.7 Macrophage.” Am J Chin Med. 2019;47(7):1589-1609. doi: 10.1142/S0192415X19500812. Epub 2019 Oct 23.
[17] Choi SY, Park JS, Shon CH, Lee CY, Ryu JM, Son DJ, Hwang BY, Yoo HS, Cho YC, Lee J, Kim JW, Roh YS (2019) – “Fermented Korean Red Ginseng Extract Enriched in Rd and Rg3 Protects against Non-Alcoholic Fatty Liver Disease through Regulation of mTORC1.” Nutrients. 2019 Dec 4;11(12). pii: E2963. doi: 10.3390/nu11122963.
[18] Saba E, Jeong D, Irfan M, Lee YY, Park SJ, Park CK, Rhee MH (2018) – “Anti-Inflammatory Activity of Rg3-Enriched Korean Red Ginseng Extract in Murine Model of Sepsis.” Evid Based Complement Alternat Med. 2018 Oct 11;2018:6874692. doi: 10.1155/2018/6874692. eCollection 2018.
[19] Kim JE, Lee W, Yang S, Cho SH, Baek MC, Song GY, Bae JS (2019) – “Suppressive effects of rare ginsenosides, Rk1 and Rg5, on HMGB1-mediated septic responses.” Food Chem Toxicol. 2019 Feb;124:45-53. doi: 10.1016/j.fct.2018.11.057. Epub 2018 Nov 26.
[20] Ahn JY, Song JY, Yun YS, Jeong G, Choi IS (2006) – « Protection of Staphylococcus aureus-infected septic mice by suppression of early acute inflammation and enhanced antimicrobial activity by ginsan.” FEMS Immunol Med Microbiol. 2006 Mar;46(2):187-97.
[21] Ahn JY, Choi IS, Shim JY, Yun EK, Yun YS, Jeong G, Song JY (2006) – “The immunomodulator ginsan induces resistance to experimental sepsis by inhibiting Toll-like receptor-mediated inflammatory signals.” Eur J Immunol. 2006 Jan;36(1):37-45.
[22] Guo M, Xiao J, Sheng X, Zhang X, Tie Y, Wang L, Zhao L, Ji X (2018) – “Ginsenoside Rg3 Mitigates Atherosclerosis Progression in Diabetic apoE-/- Mice by Skewing Macrophages to the M2 Phenotype.” Front Pharmacol. 2018 May 9;9:464. doi: 10.3389/fphar.2018.00464. eCollection 2018.
[23] Kang S, Park SJ, Lee AY, Huang J, Chung HY, Im DS (2018) – “Ginsenoside Rg3 promotes inflammation resolution through M2 macrophage polarization.” J Ginseng Res. 2018 Jan;42(1):68-74. doi: 10.1016/j.jgr.2016.12.012. Epub 2017 Jan 1.
[24] Im DS (2020) – “Pro-Resolving Effect of Ginsenosides as an Anti-Inflammatory Mechanism of Panax ginseng.” Biomolecules. 2020 Mar 13;10(3). pii: E444. doi: 10.3390/biom10030444.
[25] Kim MH, Byon YY, Ko EJ, Song JY, Yun YS, Shin T, Joo HG (2009) – “Immunomodulatory activity of ginsan, a polysaccharide of panax ginseng, on dendritic cells.” Korean J Physiol Pharmacol. 2009 Jun;13(3):169-73. doi: 10.4196/kjpp.2009.13.3.169. Epub 2009 Jun 30.
[26] Na HS, Lim YJ, Yun YS, Kweon MN, Lee HC (2010) – “Ginsan enhances humoral antibody response to orally delivered antigen.” Immune Netw. 2010 Feb;10(1):5-14. doi: 10.4110/in.2010.10.1.5. Epub 2010 Feb 28.
[27] Son KJ, Choi KR, Lee SJ, Lee H (2016) – “Immunogenic Cell Death Induced by Ginsenoside Rg3: Significance in Dendritic Cell-based Anti-tumor Immunotherapy.” Immune Netw. 2016 Feb;16(1):75-84. doi: 10.4110/in.2016.16.1.75. Epub 2016 Feb 25.
[28] Park YJ, Cho M, Choi G, Na H, Chung Y (2020) – “A Critical Regulation of Th17 Cell Responses and Autoimmune Neuro-Inflammation by Ginsenoside Rg3.” Biomolecules. 2020 Jan 10;10(1). pii: E122. doi: 10.3390/biom10010122.
[29] Cho M, Choi G, Shim I, Chung Y (2019) – “Enhanced Rg3 negatively regulates Th1 cell responses.” J Ginseng Res. 2019 Jan;43(1):49-57. doi: 10.1016/j.jgr.2017.08.003. Epub 2017 Aug 16.
[30] Jung JH, Kang TK, Oh JH, Jeong JU, Ko KP, Kim ST (2020) – “The Effect of Korean Red Ginseng on Symptoms and Inflammation in Patients With Allergic Rhinitis.” Ear Nose Throat J. 2020 Feb 19:145561320907172. doi: 10.1177/0145561320907172.
[31] Shin KK, Yi YS, Kim JK, Kim H, Hossain MA, Kim JH, Cho JY (2020) – “Korean Red Ginseng Plays An Anti-Aging Role by Modulating Expression of Aging-Related Genes and Immune Cell Subsets.” Molecules. 2020 Mar 25;25(7). pii: E1492. doi: 10.3390/molecules25071492.
[32] Jhun J, Lee J, Byun JK, Kim EK, Woo JW, Lee JH, Kwok SK, Ju JH, Park KS, Kim HY, Park SH, Cho ML (2014) – “Red ginseng extract ameliorates autoimmune arthritis via regulation of STAT3 pathway, Th17/Treg balance, and osteoclastogenesis in mice and human.” Mediators Inflamm. 2014;2014:351856. doi: 10.1155/2014/351856. Epub 2014 Jul 23.
[33] Heo SB, Lim SW, Jhun JY, Cho ML, Chung BH, Yang CW (2016) – “Immunological benefits by ginseng through reciprocal regulation of Th17 and Treg cells during cyclosporine-induced immunosuppression.” J Ginseng Res. 2016 Jan;40(1):18-27. doi: 10.1016/j.jgr.2015.04.005. Epub 2015 Apr 30.Treg
[34] Pace L, Tempez A, Arnold-Schrauf C, Lemaitre F, Bousso P, Fetler L, Sparwasser T, Amigorena S (2012) – « Regulatory T cells increase the avidity of primary CD8+ T cell responses and promote memory.” Science. 2012 Oct 26;338(6106):532-6. doi: 10.1126/science.1227049.
[35] Kim HI, Kim JK, Kim JY, Han MJ, Kim DH (2019) – “Fermented red ginseng and ginsenoside Rd alleviate ovalbumin-induced allergic rhinitis in mice by suppressing IgE, interleukin-4, and interleukin-5 expression.” J Ginseng Res. 2019 Oct;43(4):635-644. doi: 10.1016/j.jgr.2019.02.006. Epub 2019 Mar 7.
[36] Park HY, Lee SH, Lee KS, Yoon HK, Yoo YC, Lee J, Choi JE, Kim PH, Park SR (2015) – “Ginsenoside Rg1 and 20(S)-Rg3 Induce IgA Production by Mouse B Cells.” Immune Netw. 2015 Dec;15(6):331-6. doi: 10.4110/in.2015.15.6.331. Epub 2015 Dec 24.
[37] Zhang B, Zhou WJ, Gu CJ, Wu K, Yang HL, Mei J, Yu JJ, Hou XF, Sun JS, Xu FY, Li DJ, Jin LP, Li MQ (2018) – “The ginsenoside PPD exerts anti-endometriosis effects by suppressing estrogen receptor-mediated inhibition of endometrial stromal cell autophagy and NK cell cytotoxicity.” Cell Death Dis. 2018 May 1;9(5):574. doi: 10.1038/s41419-018-0581-2.
[38] Lu P, Su W, Miao ZH, Niu HR, Liu J, Hua QL (2008) – “Effect and mechanism of ginsenoside Rg3 on postoperative life span of patients with non-small cell lung cancer.” Chin J Integr Med. 2008 Mar;14(1):33-6. doi: 10.1007/s11655-007-9002.
[39] Shin KK, Yi YS, Kim JK, Kim H, Hossain MA, Kim JH, Cho JY (2020) – “Korean Red Ginseng Plays An Anti-Aging Role by Modulating Expression of Aging-Related Genes and Immune Cell Subsets.” Molecules. 2020 Mar 25;25(7). pii: E1492. doi: 10.3390/molecules25071492.
[40] Sun Y, Guo M, Feng Y, Zheng H, Lei P, Ma X, Han X, Guan H, Hou D (2016) – “Effect of ginseng polysaccharides on NK cell cytotoxicity in immunosuppressed mice.” Exp Ther Med. 2016 Dec;12(6):3773-3777. doi: 10.3892/etm.2016.3840. Epub 2016 Oct 26.
[41] Wright S, Altman E (2020) – “Inhibition of Herpes Simplex Viruses, Types 1 and 2, by Ginsenoside 20(S)-Rg3.” J Microbiol Biotechnol. 2020 Jan 28;30(1):101-108. doi: 10.4014/jmb.1908.08047.
[42] Yang H, Oh KH, Kim HJ, Cho YH, Yoo YC (2018) – “Ginsenoside-Rb2 and 20(S)-Ginsenoside-Rg3 from Korean Red Ginseng Prevent Rotavirus Infection in Newborn Mice.” J Microbiol Biotechnol. 2018 Mar 28;28(3):391-396. doi: 10.4014/jmb.1801.01006.
[43] Kim SJ, Jang JY, Kim EJ, Cho EK, Ahn DG, Kim C, Park HS, Jeong SW, Lee SH, Kim SG, Kim YS, Kim HS, Kim BS, Lee J, Siddiqui A (2017) – “Ginsenoside Rg3 restores hepatitis C virus-induced aberrant mitochondrial dynamics and inhibits virus propagation.” Hepatology. 2017 Sep;66(3):758-771. doi: 10.1002/hep.29177. Epub 2017 Aug 1.
[44] Kang LJ, Choi YJ, Lee SG (2013) – “Stimulation of TRAF6/TAK1 degradation and inhibition of JNK/AP-1 signalling by ginsenoside Rg3 attenuates hepatitis B virus replication.” Int J Biochem Cell Biol. 2013 Nov;45(11):2612-21. doi: 10.1016/j.biocel.2013.08.016. Epub 2013 Sep 1.
[45] Cho YJ, Son HJ, Kim KS (2014) – “A 14-week randomized, placebo-controlled, double-blind clinical trial to evaluate the efficacy and safety of ginseng polysaccharide (Y-75).” J Transl Med. 2014 Oct 9;12:283. doi: 10.1186/s12967-014-0283-1.
[46] Yonggang T, Yiming M, Heying Z, Cheng S, Qiushi W, Xianghong Y, Wei Z, Huawei Z, Shan F (2012) – “Maturation and upregulation of functions of murine dendritic cells (DCs) under the influence of purified aromatic-turmerone (AR).” Hum Vaccin Immunother. 2012 Oct;8(10):1416-24. doi: 10.4161/hv.21526. Epub 2012 Oct 1.
[47] Kim D, Suh Y, Lee H, Lee Y (2013) – “Immune activation and antitumor response of ar-turmerone on P388D1 lymphoblast cell implanted tumors.” Int J Mol Med. 2013 Feb;31(2):386-92. doi: 10.3892/ijmm.2012.1196. Epub 2012 Nov 29.
[48] Li YL, Du ZY, Li PH, Yan L, Zhou W, Tang YD, Liu GR, Fang YX, Zhang K, Dong CZ, Chen HX (2018) – “Aromatic-turmerone ameliorates imiquimod-induced psoriasis-like inflammation of BALB/c mice.” Int Immunopharmacol. 2018 Nov;64:319-325. doi: 10.1016/j.intimp.2018.09.015. Epub 2018 Sep 19.
[49] Yue GG, Chan BC, Hon PM, Lee MY, Fung KP, Leung PC, Lau CB (2010) – “Evaluation of in vitro anti-proliferative and immunomodulatory activities of compounds isolated from Curcuma longa.” Food Chem Toxicol. 2010 Aug-Sep;48(8-9):2011-20. doi: 10.1016/j.fct.2010.04.039. Epub 2010 May 9.
[50] Li R, Wang L (2019) – “Baicalin inhibits influenza virus A replication via activation of type I IFN signaling by reducing miR 146a.” Mol Med Rep. 2019 Dec;20(6):5041-5049. doi: 10.3892/mmr.2019.10743. Epub 2019 Oct 15.
[51] Oo A, Teoh BT, Sam SS, Bakar SA, Zandi K (2019) – “Baicalein and baicalin as Zika virus inhibitors.” Arch Virol. 2019 Feb;164(2):585-593. doi: 10.1007/s00705-018-4083-4. Epub 2018 Nov 3.
[52] Qian K, Kong ZR, Zhang J, Cheng XW, Wu ZY, Gu CX, Shao HX, Qin AJ. (2018) – “Baicalin is an inhibitor of subgroup J avian leukosis virus infection.” Virus Res. 2018 Mar 15;248:63-70. doi: 10.1016/j.virusres.2018.02.017. Epub 2018 Feb 23.
[53] Li X, Liu Y, Wu T, Jin Y, Cheng J, Wan C, Qian W, Xing F, Shi W (2015) – “The Antiviral Effect of Baicalin on Enterovirus 71 In Vitro.” Viruses. 2015 Aug 19;7(8):4756-71. doi: 10.3390/v7082841.
[54] Ding Y, Dou J, Teng Z, Yu J, Wang T, Lu N, Wang H, Zhou C (2014) – “Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase.” Arch Virol. 2014 Dec;159(12):3269-78. doi: 10.1007/s00705-014-2192-2. Epub 2014 Jul 31.
[55] Chen F, Chan KH, Jiang Y, Kao RY, Lu HT, Fan KW, Cheng VC, Tsui WH, Hung IF, Lee TS, Guan Y, Peiris JS, Yuen KY (2004) – “In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds.” J Clin Virol. 2004 Sep;31(1):69-75.
[56] Meng X, Hu L, Li W (2019) – “Baicalin ameliorates lipopolysaccharide-induced acute lung injury in mice by suppressing oxidative stress and inflammation via the activation of the Nrf2-mediated HO-1 signaling pathway.” Naunyn Schmiedebergs Arch Pharmacol. 2019 Jul 4. doi: 10.1007/s00210-019-01680-9.
[57] Zhi HJ, Zhu HY, Zhang YY, Lu Y, Li H, Chen DF (2019) – “In vivo effect of quantified flavonoids-enriched extract of Scutellaria baicalensis root on acute lung injury induced by influenza A virus.” Phytomedicine. 2019 Apr;57:105-116. doi: 10.1016/j.phymed.2018.12.009. Epub 2018 Dec 10.
[58] Peng LY, Yuan M, Song K, Yu JL, Li JH, Huang JN, Yi PF, Fu BD, Shen HQ (2019) – “Baicalin alleviated APEC-induced acute lung injury in chicken by inhibiting NF-κB pathway activation.” Int Immunopharmacol. 2019 Jul;72:467-472. doi: 10.1016/j.intimp.2019.04.046. Epub 2019 Apr 28.
[59] Deng J, Wang DX, Liang AL, Tang J, Xiang DK (2017) – “Effects of baicalin on alveolar fluid clearance and α-ENaC expression in rats with LPS-induced acute lung injury.” Can J Physiol Pharmacol. 2017 Feb;95(2):122-128. doi: 10.1139/cjpp-2016-0212. Epub 2016 Aug 31.
[60] Shi H, Ren K, Lv B, Zhang W, Zhao Y, Tan RX, Li E (2016) – “Baicalin from Scutellaria baicalensis blocks respiratory syncytial virus (RSV) infection and reduces inflammatory cell infiltration and lung injury in mice.” Sci Rep. 2016 Oct 21;6:35851. doi: 10.1038/srep35851.
[61] Wang L, Zhang Y, Fan G, Ren JN, Zhang LL, Pan SY (2019) – “Effects of orange essential oil on intestinal microflora in mice.” J Sci Food Agric. 2019 Jun;99(8):4019-4028. doi: 10.1002/jsfa.9629. Epub 2019 Mar 12.